Ruben A Mesa Selected Research

Ruben A Mesa Research Topics

Disease

96	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 03/2002
46	Neoplasms (Cancer) 01/2022 - 02/2002
35	Splenomegaly 04/2021 - 06/2002
27	Anemia 04/2021 - 07/2004
26	Polycythemia Vera 12/2022 - 08/2002
21	Essential Thrombocythemia 12/2022 - 04/2005
18	Cytopenia 06/2020 - 08/2002
14	Fatigue 12/2020 - 03/2006
13	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2004
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2005
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2017 - 08/2003
8	Leukemia 01/2021 - 03/2006
8	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2019 - 08/2003
6	Fibrosis (Cirrhosis) 01/2021 - 03/2002
5	Pain (Aches) 04/2019 - 08/2005
5	Disease Progression 05/2017 - 02/2005
5	Thrombocytosis (Thrombocythemia) 09/2010 - 05/2002
4	Blast Crisis (Blast Phase) 10/2020 - 09/2012
4	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 02/2002
3	Philadelphia Chromosome 10/2017 - 07/2011
3	Fever (Fevers) 05/2017 - 07/2013
3	Polycythemia (Erythrocytosis) 06/2013 - 08/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2012 - 06/2007
3	Leukocytosis (Pleocytosis) 09/2009 - 07/2004
2	Inflammation (Inflammations) 04/2021 - 01/2015
2	Obesity 01/2020 - 04/2014
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
2	Dyspnea (Shortness of Breath) 04/2019 - 01/2017
2	Pruritus (Itching) 04/2019 - 07/2013
2	Sepsis (Septicemia) 05/2017 - 01/2017
2	Pneumonia (Pneumonitis) 05/2017 - 01/2017
2	Thrombosis (Thrombus) 01/2017 - 06/2006
2	Nausea 01/2017 - 04/2012
2	Diarrhea 01/2017 - 04/2012
2	Weight Loss (Weight Reduction) 07/2013 - 11/2011
2	Venous Thrombosis (Deep-Vein Thrombosis) 06/2013 - 06/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2012 - 08/2004
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 06/2007 - 11/2006
2	Portal Hypertension 07/2006 - 08/2005
2	Hepatomegaly 02/2006 - 02/2005
2	Osteosclerosis 01/2006 - 07/2004
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

45	ruxolitinibIBA 01/2022 - 09/2009
24	Janus Kinase InhibitorsIBA 01/2022 - 01/2013
12	fedratinibIBA 01/2022 - 09/2009
10	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2021 - 04/2012
9	Syntex adjuvant formulationIBA 01/2022 - 07/2011
9	Hemoglobins (Hemoglobin)IBA 04/2021 - 04/2003
9	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 06/2020 - 04/2012
8	Pharmaceutical PreparationsIBA 06/2020 - 04/2003
8	Thalidomide (Thalomid)FDA Link 01/2011 - 05/2002
7	Janus KinasesIBA 01/2018 - 03/2012
6	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 05/2008
6	Janus Kinase 2IBA 05/2021 - 03/2008
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
6	Janus Kinase 1IBA 12/2017 - 12/2013
6	CytokinesIBA 07/2015 - 05/2002
5	Phosphotransferases (Kinase)IBA 01/2020 - 07/2005
5	Lenalidomide (CC 5013)FDA Link 04/2012 - 08/2006
5	Prednisone (Sone)FDA LinkGeneric 01/2011 - 04/2003
4	pomalidomideIBA 01/2015 - 09/2009
4	Imatinib Mesylate (Gleevec)FDA Link 03/2013 - 05/2002
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2007 - 04/2005
3	InterferonsIBA 12/2022 - 05/2011
3	CollagenIBA 01/2021 - 07/2004
3	Immunomodulating AgentsIBA 07/2017 - 01/2010
3	Erythropoietin FDA Link 01/2013 - 08/2002
3	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2012 - 07/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2008 - 03/2002
2	IronIBA 04/2021 - 01/2015
2	Decitabine FDA Link 10/2020 - 12/2018
2	CreatinineIBA 10/2017 - 08/2015
2	Azacitidine (5 Azacytidine)FDA Link 10/2015 - 01/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2014 - 06/2013
2	adavosertibIBA 04/2014 - 03/2012
2	Checkpoint Kinase 1IBA 11/2011 - 07/2005
2	17-aminogeldanamycinIBA 11/2011 - 07/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2011 - 07/2005
2	tanespimycin (17AAG)IBA 11/2011 - 07/2005
2	Biological ProductsIBA 05/2011 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 11/2006
2	Etanercept (Enbrel)FDA Link 08/2002 - 03/2002
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	Danazol (Azol)FDA LinkGeneric 04/2021
1	Long Noncoding RNAIBA 01/2021
1	GATA1 Transcription FactorIBA 01/2021
1	NucleophosminIBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021

Therapy/Procedure

72	Therapeutics 12/2022 - 02/2002
8	Stem Cell Transplantation 11/2019 - 08/2003
6	Erythrocyte Transfusion 12/2017 - 07/2004
4	Drug Therapy (Chemotherapy) 12/2014 - 05/2003
4	Splenectomy 07/2006 - 05/2003
3	Transplantation 10/2020 - 08/2011
3	Cell Transplantation 10/2020 - 11/2015
3	Radiotherapy 12/2018 - 10/2003
3	Immunomodulation 12/2013 - 09/2009
2	Hematopoietic Stem Cell Transplantation 01/2019 - 02/2006
1	Resistance Training 12/2020